Skip to search formSkip to main contentSkip to account menu

CJC 1131

Known as: CJC-1131, CJC1131 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background Alzheimer's disease (AD) is one of the most common neurodegenerative disorders. Recent studies have shown that… 
2016
2016
The Postgraduate Year (PGY) Program allows doctors-in-training to learn about the diagnosis, treatment and nursing of various… 
2015
2015
1. Babor R, Talbot M, Tyndal A. Treatment of upper gastrointestinal leaks with a removable, covered, self-expanding metallic… 
2012
2012
I develop a toolbox to analyze the statistical properties of multivariate Markov-switching models. I first derive analytical… 
2010
2010
Time of arrival (TOA) estimation in multipath dense environment for UWB backscattering radio frequency identification (RFID… 
2006
2006
New agents are being added to the armamentarium of drugs used for the treatment of diabetes mellitus. Today, extensive research… 
2005
2005
Glucagon-like peptide-1 (GLP-1) has significant effects on insulin secretion and glucose regulation and levels of this… 
Review
2003
Review
2003
ConjuChem is developing CJC-1131, a drug affinity complex conjugate of glucagon-like peptide 1 for the potential treatment of… 
Review
2003
Review
2003
Glucagon-like peptide-1-(7-36)-amide (GLP-1) is a potent blood glucose-lowering hormone now under investigation for use as a… 
Review
1984
Review
1984
A microagglutination test was developed to determine campylobacter titers in swine with proliferative enteritis. Formalinized…